Fund I Overview
PassionBio Fund I
PassionBio Capital Fund I is a dedicated EuVECA investment vehicle focused on equity investments in selected development stage biopharma programs. The fund targets assets with defined scientific rationale, identifiable clinical development paths, and potential for measurable improvement relative to existing standards of care.
For all regulatory, legal, and contractual purposes, the fund operates under the registered name PBC I EuVECA GmbH & Co KG. In external communication, the fund is referred to as PassionBio Capital Fund I.
The fund was incorporated on 03FEB’26 and is in the process of being registered in the commercial register. Investment activity will commence only after completion of the formal registration process and all required regulatory steps.
Investment Scope
The fund invests selectively in clinical and late preclinical programs that align with the scientific and therapeutic focus of PassionBio. Investment decisions are based on assessment of unmet medical need, development feasibility, and value creation potential through active clinical and operational involvement.
Capital is deployed with the objective of enabling focused development milestones rather than broad portfolio exposure.
Investment Process
Scientific evaluation and development strategy are driven by the operating entity PassionBio.tech FlexCo. This includes program sourcing, technical and clinical assessment, and development planning.
Investment decisions follow a structured governance process and are executed at fund level in accordance with the applicable regulatory framework.
Current Status
The fund was incorporated on 03FEB’26 and is in the process of being registered in the commercial register. Detailed information on fund structure, terms, and investor related matters will be provided following completion of the fund’s registration process.
This page does not constitute an offer to sell or a solicitation to invest in any financial instrument.